Note: Ingredients listed on restricted chemical lists
EC/CAS
208-096-8/509-34-2
Name of the chemical
Colouring agent CI 45170 and CI 45170:1 (Basic Violet 10)
Concentration
30%
EC/CAS
122-99-6
Name of the chemical
2-Phenoxyethanol
Concentration
25%
EC/CAS
100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
20% 14% 06-2 6% 06-0
EC/CAS
102-71-6
Name of the chemical
triethanolamine
Concentration
4% 90506- 291-933- 1% 69-7
General Information
Version
1.0
Revision date
2025-05-15
Product name
Ballpen ink (red） not applicable
1.2.1 Relevant identified uses
Preparation for writing instruments
Emergency telephone
+86-512-63331385
Icons in SDS
Company Information
company name
suzhou xiongying ink technology co. ltd
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302, H315, H318, H411
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No 1272/2008 [CLP Classification of the substance or mixture
Additional information
For the full text of Classification and Hazard-statements: see SECTION 16.
Signal word
Danger
Hazard statements
H302 Harmful if swallowed. H315 Causes skin irritation. H318 Causes serious eye damage. H411 Toxic to aquatic life with long lasting effects.
Precautionary statements
P273 Avoid release to the environment. P280 Wear protective gloves/protective clothing/eye protection/face protection. P310 Immediately call a POISON CENTER/doctor/… P391 Collect spillage. P302+P352 IF ON SKIN: Wash with plenty of water/… P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Supplemental label elements
no data available 2.3. Other hazards no data available
2.1 Classification of the substance or mixture
2.1.1. Classification according to Regulation (EC) No 1272/2008 (CLP) Acute Tox. 4,H302 Skin Irrit. 2,H315 Eye Dam. 1,H318 Aquatic Chronic 2,H411 2.1.2. Additional information For the full text of Classification and Hazard-statements: see SECTION 16.
